EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Steve Dickman

Company creation: Does in-house formation outweigh traditional investments for VCs?

CBT Advisors

Jerome M. Adams, MD, MPH,

Xcelerate Keynotes

US Department of Health and Human Services

7:30am - 8:00am 30 mins
Info
Main Agenda
Registration and Exhibition // Open all day

Registration: Main Lobby

Exhibition: Exhibit Hall A Foyer 

The registration desk and exhibition will be open all day.

7:30am - 8:30am 60 mins
Info
Networking
Continental Breakfast

Exhibit Hall A Foyer

8:00am - 5:30pm 570 mins
Info
Main Agenda
One-to-one meetings

Exhibit Hall A

8:30am - 9:15am 45 mins
Info
Therapeutic Spotlight
New innovation models in rare disease drug development
  • Moderator Craig Martin - Board Member and Chair of the Corporate Alliance, Global Genes
  • Speaker Chris Adams - CEO, Cydan
  • Speaker Daniel Bauer - Principal Investigator, Boston Children’s Hospital
  • Speaker Alberto Grignolo - Corporate VP, PAREXEL International
  • Speaker Alvin Shih - CEO, Enzyvant

Plaza Level, Room 108

8:30am - 9:15am 45 mins
Info
EBD Academy
EBD Academy Buzz session: Mastering the fund raise pitch to investors
  • Speaker Joe Dillon - President and CEO, Dillon Capital Strategies

Plaza Level, Room 109

This session is designed to help company executives involved in fund raising to create pitches that have the potential to attract investors and reduce the time it takes to secure funding. Successful pitches rely on many factors beyond communicating the science. During this session we will explore proven pitch tactics that can differentiate your opportunity from the many others investors see every day.

What we will cover:
•        The top 5 things investors look for first in a pitch
•        The top 5 things that turn investors off right away
•        Knowing your audience – pitch customizing
•        What to communicate and when – before and after CDA
•        Selling optimism while maintaining credibility
•        Maintaining momentum after the first pitch
•        Group discussion – sharing pitch experiences

9:15am - 10:15am 60 mins
Info
Therapeutic Spotlight
Company presentations
9:30am - 10:15am 45 mins
Info
Strategy and Business
Company creation: Does in-house formation outweigh traditional investments for VCs?
  • Moderator Steve Dickman - CEO, CBT Advisors
  • Panelist Jason Coloma - Entrepreneur-In-Residence, Third Rock Ventures
  • Panelist Michael Gladstone - Principal, Atlas Venture
  • Panelist Josh Mandel-Brehm - CEO, CAMP4 Therapeutics; Entrepreneur Partner, Polaris Partners
  • Panelist Anna Turetsky - VP, Lightstone Ventures

Plaza Level, Room 109

Recently, traditional VCs are taking company creation into their own hands instead of making traditional investments in new technologies and companies. Why is this happening? Is it a lack of good ideas coming out of biotech companies? A lack of quality management? Is this becoming the new normal and preferred route for VCs? Hear from this panel on recent trends in company creation versus traditional investments and how it is affecting the ecosystem.

10:30am - 11:15am 45 mins
Info
Therapeutic Spotlight
Big bets in underserved therapeutic areas
  • Moderator Philip Hemme - Co-Founder and CEO, Labiotech
  • Panelist Girish Aakalu - VP and Global Head of External Innovation, Ipsen
  • Panelist Joep Muijrers - CFO, PureTech Health
  • Panelist Hassan Naqvi - Director, Corporate Partnerships, Johns Hopkins Technology Ventures
  • Panelist Leslie Williams - President and CEO, ImmusanT, Inc.

Plaza Level, Room 108

The majority of R&D targets and approaches are in the same therapeutic areas but there are a lot of new and exciting opportunities in emerging and underserved therapeutic areas. Sit down with industry executives to discuss the strategy and approaches in addressing these unmet needs and why going into these areas alone can actually be wildly successful.

11:15am - 12:15pm 60 mins
Info
Therapeutic Spotlight
Company presentations
12:15pm - 1:15pm 60 mins
Info
Networking
Luncheon

Exhibit Hall A Foyer

Overflow seating Plaza Level, Rooms 110 and 111

1:15pm - 2:00pm 45 mins
Info
Therapeutic Spotlight
Partnering in oncology
  • Moderator Philip Kenner - Principal, ClearView Healthcare Partners
  • Panelist Christiana Bardon - Managing Director, Burrage Capital and MPM Capital, Oncology Impact Fund
  • Panelist Jonathan Lanfear - Global Head, R&D Business Development, Takeda
  • Panelist Philippe Lopes-Fernandes - Senior VP, Global Head of Business Development & Alliance Management, Merck KGaA, Darmstadt, Germany
  • Panelist Patrick Tricoli - CEO, Nanobiotix USA

Plaza Level, Room 108

1:15pm - 2:00pm 45 mins
Info
Special Presentation
Live recording of "The Readout LOUD" podcast with STAT
  • Speaker Adam Feuerstein - Senior Writer, Biotech, STAT
  • Speaker Damian Garde - National Biotech Reporter, STAT
  • Speaker Rebecca Robbins - Business Reporter, STAT

Plaza Level, Room 109

Join the STAT biotech team for the first ever live recording of "The Readout LOUD" — STAT's weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

2:45pm - 4:00pm 75 mins
Info
Networking
Exhibit hall happy hour

Exhibit Hall A Foyer

3:30pm - 5:30pm 120 mins
Info
Xcelerate Keynote Series
Xcelerate Keynotes
  • Speaker Jerome M. Adams, MD, MPH, - US Surgeon General, US Department of Health and Human Services
  • Speaker Alexis Borisy - Partner, Third Rock Ventures; Chair, National Venture Capital Association, Third Rock Ventures
  • Speaker Susan Hockfield - President Emerita and Professor of Neuroscience, MIT
  • Speaker Elizabeth Nabel - President, Brigham Health
  • Speaker George Yancopoulos - President and Chief Scientific Officer, Regeneron Pharmaceuticals

Level 2, Veterans Memorial Auditorium

Presented by Xconomy, Xcelerate features a curated series of spotlight keynotes from life science luminaries that will capture the attention of the entire festival. As life sciences, healthcare and drug development are undergoing unprecedented change, including the arrival of groundbreaking new treatments and the growing backlash against high drug prices, the keynote speakers will share insights on how their areas of life science and healthcare are adapting to all this change, and what other disruptive forces they see on the horizon.

6:30pm - 9:30pm 180 mins
Info
Networking
Evening Networking Reception

The Royale
279 Tremont St, Boston, MA 02116

Thursday, don’t miss the Biotech Week Boston Festival Party at The Royale nightclub. This is the only event where you can kick back and meet attendees from ALL of the official events that are part of Biotech Week Boston. Unwind, network in a fun atmosphere, and enjoy an evening of rock and roll, complete with a headline band.

Showing of Streams